Archer A, Kutter C, Williams C
Methods Mol Biol. 2022; 2418:313-343.
PMID: 35119673
DOI: 10.1007/978-1-0716-1920-9_18.
Shen J, Yuan Z, Sheng J, Feng X, Wang H, Wang Y
J Cancer. 2022; 13(1):112-123.
PMID: 34976175
PMC: 8692688.
DOI: 10.7150/jca.62630.
Tu J, Yang H, Jiang L, Chen Y, Li Z, Li L
Int J Endocrinol. 2021; 2021:5572063.
PMID: 34122542
PMC: 8169271.
DOI: 10.1155/2021/5572063.
Verma A, Mittal R
Indian J Clin Biochem. 2021; 36(2):194-199.
PMID: 33867710
PMC: 7994493.
DOI: 10.1007/s12291-020-00881-x.
Piergentili R, Zaami S, Cavaliere A, Signore F, Scambia G, Mattei A
Int J Mol Sci. 2021; 22(6).
PMID: 33808791
PMC: 8003471.
DOI: 10.3390/ijms22063151.
MicroRNA as Epigenetic Modifiers in Endometrial Cancer: A Systematic Review.
Favier A, Rocher G, Larsen A, Delangle R, Uzan C, Sabbah M
Cancers (Basel). 2021; 13(5).
PMID: 33800944
PMC: 7961497.
DOI: 10.3390/cancers13051137.
Downregulation of miR-30c-5p expression in colorectal cancer tissue is sex-dependent.
Herichova I, Reis R, Hasakova K, Vician M
Physiol Res. 2021; 69(Suppl 3):S479-S487.
PMID: 33476170
PMC: 8603722.
DOI: 10.33549/physiolres.934598.
MTA1, a Target of Resveratrol, Promotes Epithelial-Mesenchymal Transition of Endometriosis via ZEB2.
Kong X, Xu X, Zhou L, Zhu M, Yao S, Ding Y
Mol Ther Methods Clin Dev. 2020; 19:295-306.
PMID: 33145366
PMC: 7578554.
DOI: 10.1016/j.omtm.2020.09.013.
Long non-coding RNA CASC7 is associated with the pathogenesis of heart failure via modulating the expression of miR-30c.
Xu Y, Liu Y, Cai R, He S, Dai R, Yang X
J Cell Mol Med. 2020; 24(19):11500-11511.
PMID: 32860492
PMC: 7576250.
DOI: 10.1111/jcmm.15764.
Role of MicroRNA-30c in cancer progression.
Han W, Cui H, Liang J, Su X
J Cancer. 2020; 11(9):2593-2601.
PMID: 32201529
PMC: 7066027.
DOI: 10.7150/jca.38449.
Effects of Sorafenib and Arsenic Trioxide on U937 and KG-1 Cell Lines: Apoptosis or Autophagy?.
Haghi A, Salami M, Mohammadi Kian M, Nikbakht M, Mohammadi S, Chahardouli B
Cell J. 2019; 22(3):253-262.
PMID: 31863650
PMC: 6947003.
DOI: 10.22074/cellj.2020.6728.
Molecular characterization of carcinosarcomas arising in the uterus and ovaries.
Brunetti M, Agostini A, Staurseth J, Davidson B, Heim S, Micci F
Oncotarget. 2019; 10(38):3614-3624.
PMID: 31217897
PMC: 6557202.
DOI: 10.18632/oncotarget.26942.
The Use of microRNAs in the Management of Endometrial Cancer: A Meta-Analysis.
Delangle R, De Foucher T, Larsen A, Sabbah M, Azais H, Bendifallah S
Cancers (Basel). 2019; 11(6).
PMID: 31208108
PMC: 6628044.
DOI: 10.3390/cancers11060832.
miR-940 potentially promotes proliferation and metastasis of endometrial carcinoma through regulation of MRVI1.
Zhou Z, Xu Y, Wang L, Kong Y
Biosci Rep. 2019; 39(6).
PMID: 31085718
PMC: 6559375.
DOI: 10.1042/BSR20190077.
Non-Coding RNAs in Endometrial Physiopathology.
La Ferlita A, Battaglia R, Andronico F, Caruso S, Cianci A, Purrello M
Int J Mol Sci. 2018; 19(7).
PMID: 30037059
PMC: 6073439.
DOI: 10.3390/ijms19072120.
Expression of miR-30c and BCL-9 in gastric carcinoma tissues and their function in the development of gastric cancer.
Han W, Mu Y, Zhang Z, Su X
Oncol Lett. 2018; 16(2):2416-2426.
PMID: 30013632
PMC: 6036597.
DOI: 10.3892/ol.2018.8934.
Oncolytic activity of a coxsackievirus B3 strain in human endometrial cancer cell lines.
Lin Y, Wang W, Wan J, Yang Y, Fu W, Pan D
Virol J. 2018; 15(1):65.
PMID: 29631630
PMC: 5891967.
DOI: 10.1186/s12985-018-0975-x.
MicroRNA-30c as a novel diagnostic biomarker for primary and secondary B-cell lymphoma of the CNS.
Baraniskin A, Chomiak M, Ahle G, Gress T, Buchholz M, Turewicz M
J Neurooncol. 2018; 137(3):463-468.
PMID: 29327175
DOI: 10.1007/s11060-018-2749-0.
Anti-Vascular Endothelial Growth Factor Targeting by Curcumin and Thalidomide in Acute Myeloid Leukemia Cells.
Salemi M, Mohammadi S, Ghavamzadeh A, Nikbakht M
Asian Pac J Cancer Prev. 2017; 18(11):3055-3061.
PMID: 29172279
PMC: 5773791.
DOI: 10.22034/APJCP.2017.18.11.3055.
Estrogen Repression of MicroRNAs Is Associated with High Guanine Content in the Terminal Loop Sequences of Their Precursors.
Cohen A, Burgos-Aceves M, Kahan T, Smith Y
Biomedicines. 2017; 5(3).
PMID: 28805722
PMC: 5618305.
DOI: 10.3390/biomedicines5030047.